Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer

Published:2024-02 Issue: Volume:128 Page:111489
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Peiliang Wang M.D.,Yikun Li M.M.,Mengyu Zhao M.M.,Jinming Yu M.D.,Feifei Teng M.D.

Funder

Shandong First Medical University

National Natural Science Foundation of China

Chinese Academy of Medical Sciences & Peking Union Medical College

Shandong Province Natural Science Foundation

Publisher

Elsevier BV

Reference50 articles.

1. Five-year outcomes from the randomized, phase III trials checkmate 017 and 057: Nivolumab versus docetaxel in previously treated non-small-cell lung cancer;Borghaei;J Clin Oncol.,2021

2. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

3. Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade;Zhao;Cancers (basel),2020

4. Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: Incidence and risk factors;Suresh;J Thorac Oncol.,2018

5. Radiation-induced lung injury: Assessment and management;Hanania;Chest,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP